Representatives from the pharmaceutical sector urged EU Commission President Ursula von der Leyen to negotiate with the US over tariffs to avoid supply chain issues. The sector narrowly escaped tariffs recently, but future risks remain. Major companies like Novo Nordisk, Bayer, and Sanofi participated in discussions emphasizing the need for reduced non-tariff barriers and a strategic dialogue to protect patients and businesses. Concerns were raised about the impact of tariffs on both European and American patients, particularly affecting countries like Ireland with significant US pharmaceutical operations. Article complet (Euronews.com)